Vector Laboratories Completes $124 Million Buyout; Initiates Acquisition Strategy; Appoints Former 10x Genomics and Maravai LifeSciences Exec as CEO; Launches VectaMount Express
BURLINGAME, Calif.September 7, 2021 Vector Laboratories, the market leader in the development and manufacture of labeling and detection reagents for biomedical research, today announced that it has closed a $124 million cash buyout, backed by... Read more
